Jean-François Kaux1, Marc Bouvard2, Christelle Lecut3, Cécile Oury4, André Gothot3, Mikel Sanchez5, Jean-Michel Crielaard1. 1. Department of Physical Medicine and Sports Traumatology, CHU Liège, Belgium ; Department of Pluridisciplinary Medicine and Sports Traumatology (SPORTS ), CHU Liège, Belgium ; Department of Motricity Sciences, University of Liège, Allée des Sports, Belgium. 2. Centre for Biology and Sports Medicine, Pau, France. 3. Laboratory Hematology Department, University of Liège, University Hospital Sart-Tilman, Liège, Belgium. 4. Laboratory of Thrombosis and Haemostasis, GIGA - Cardiovascular Sciences, University of Liège, Belgium. 5. Unidad de Cirugía Artroscópica, Vitoria-Gasteiz, Spain.
Abstract
BACKGROUND: platelet-rich plasma (PRP) infiltration represents a recent therapy for chronic tendinopathies. However, in the literature, this treatment remains controversial. PURPOSE: we suggest some ideas for improving this treatment. METHODS: these suggestions were based on a review of published studies and our clinical experience. CONCLUSION: optimizing the technique for PRP collection is paramount. Different risk factors must be corrected before infiltration and chronic tendinopathies must be carefully selected. Finally, post-infiltration rehabilitation remains absolutely critical. Standardization of the use of PRP remains necessary in order to optimize the results.
BACKGROUND: platelet-rich plasma (PRP) infiltration represents a recent therapy for chronic tendinopathies. However, in the literature, this treatment remains controversial. PURPOSE: we suggest some ideas for improving this treatment. METHODS: these suggestions were based on a review of published studies and our clinical experience. CONCLUSION: optimizing the technique for PRP collection is paramount. Different risk factors must be corrected before infiltration and chronic tendinopathies must be carefully selected. Finally, post-infiltration rehabilitation remains absolutely critical. Standardization of the use of PRP remains necessary in order to optimize the results.
Authors: M Cattaneo; C Cerletti; P Harrison; C P M Hayward; D Kenny; D Nugent; P Nurden; A K Rao; A H Schmaier; S P Watson; F Lussana; M T Pugliano; A D Michelson Journal: J Thromb Haemost Date: 2013-04-10 Impact factor: 5.824
Authors: Thomas Kirchgesner; Ahmed Larbi; Patrick Omoumi; Jacques Malghem; Nadia Zamali; Julien Manelfe; Frédéric Lecouvet; Bruno Vande Berg; Sahlya Djebbar; Benjamin Dallaudière Journal: Joint Bone Spine Date: 2014-06-21 Impact factor: 4.929